>> This will be of interest to those who feel
>> vulnerable when coming to the end of the
[quoted text clipped - 9 lines]
> to read the article. But if they are stating this for Tamoxifen, I guess
> it goes for those of us taking Arimidex too.
No that is not the case. The study was specifically of Tamoxifen, not
any alternative drugs. I must emphasise that Arimidex is not the same
class of drug and does not work the same way.
> If so, this alarms me instead of making me feel more positive about the
> future. It is because I never read anything before about the drugs
[quoted text clipped - 5 lines]
> I thought my Oncologist has told me he will continue to keep me on
> Arimidex continually until they find it can be dangerous to do so.
Indeed that is how Arimidex and other aromatase inhibitors work. But it
is not how Tamoxifen works. Tamoxifen acts as an 'alternative' to
estrogen, competing with it for the receptor sites. At present no-one is
saying that the same applies to aromatase inhibitors, they haven't
really been in common use long enough for this sort of follow-up trial
to be done. That also applies to new alternatives of the Tamoxifen
class such as Evista.
> Frankly, I think they need to come up with solid proof of this new
> theory before they can possibly endanger ER+ patients by telling them
[quoted text clipped - 3 lines]
> bc after stopping Tamoxifen does not convince me we all would be that
> lucky.
As far a I know no-one has proposed any theory for how this happens.
This is not a theoretical article, it is the statistical results of two
studies of 7145 and 2494 women respectively. No-one is talking about
endangering patients or indeed about making any change in treatment. It
is already normal practice to discontinue Tamoxifen after five years as
it is well known that continuing it does not offer benefit.
> My hope is still on being able to continue Arimidex as long as my body
> is able to produce "any" estrogen. I would not feel safe trusting this
> latest "theory".
>
> Thanks so much for sharing, Tim. I will try to see if I can find
> someway to access the article and learn more about what is going on.
I can email this article and a preceding one that gives more data, to
you if you like. Medscape has an "email to colleague" facility.
Tim
Bea Oo - 01 Mar 2007 12:58 GMT
>I can email this article and a preceding one
> that gives more data, to you if you like.
> Medscape has an "email to colleague" facility.
>Tim
Thank you for the additional info and the offer Tim. However, I will
not need you to email the article if Tamoxifen does not work the same
way as Arimidex. I misunderstood and thought they worked the same way.
Must be the reason my Onc switched me from Tamoxifen to Arimidex. He
said Tamoxifen was not the right one for me to be using.
Bea
'NO FORWARDS OR SPAM, PLEASE"
Mapoftheworld - 01 Mar 2007 14:59 GMT
There seem to many possible reasons why tamoxifen has a positive
effect even after people stop taking it:
a) Perhaps the immune system was able to clear up remaining cancer
cells while tamoxifen held them dormant
b) Tumors take a while to grow to the point of detection, so even if
the tamoxifen has no real effect after five years (i.e. cancer cells
can begin to grow after tamoxifen is stopped), you'd still see some
"lingering" benefit as it can take several years for a tumor to "show
up".
Whether aromatase inhibitors (e.g, Arimidex) also give a benefit after
they are stopped has not, to my knowledge, been studied yet. I don't
think reseachers have established yet how long they should be taken,
whereas we know that tamoxifen probably should be stopped after 5
years. The aromatase inhibitors are relatively new so it will take
some time to fully assess their long-term benefits, although several
new studies are suggesting that this class of drugs is even better
than tamoxifen (which itself is highly effective). Of course, the
benefits of aromatase inhibitors are available only to post-menopausal
women (and I guess to all men), or to those who become post-menopausal
during treatment (this is why doctors often will start peri-menopausal
women on tamoxifen and then switch after 2 or 3 years to an aromatase
inhibitor--at this point they can be almost certain that the menopause
is "real" and not a temporary effect from ovary damage from chemo).
> >I can email this article and a preceding one
> > that gives more data, to you if you like.
[quoted text clipped - 10 lines]
>
> 'NO FORWARDS OR SPAM, PLEASE"
sherry - 03 Mar 2007 04:51 GMT
> >I can email this article and a preceding one
> > that gives more data, to you if you like.
[quoted text clipped - 10 lines]
>
> 'NO FORWARDS OR SPAM, PLEASE"
Hi , this has been on my mind for sometime now, and I wanted to ask
you all a few questions. I have read an article at "
http://www.medical-health-care-information.com/encyclopedia/t/Tamoxifen.asp"
which says 'Tamoxifen is the most commonly prescribed medication for
the treatment of breast cancer. Estrogen promotes the growth of breast
cancer cells. Tamoxifen blocks the effects of estrogen on these cells.
It is often called an antiestrogen.
Tamoxifen is most effective for treating breast cancer that tests
positive for estrogen receptors (ER+). Tamoxifen is also used to
reduce the risk of breast cancer for women who have a high risk of
developing breast cancer.'.
While it must be true, I wonder what you have to say about it. Do let
me know!
Regards, sherry bove
> >This will be of interest to those who feel
> > vulnerable when coming to the end of the
[quoted text clipped - 37 lines]
>
> 'NO FORWARDS OR SPAM, PLEASE"
Hi , this has been on my mind for sometime now, and I wanted to ask
you all a few questions. I have read an article at "
http://www.medical-health-care-information.com/encyclopedia/t/Tamoxifen.asp"
which says 'Tamoxifen is the most commonly prescribed medication for
the treatment of breast cancer. Estrogen promotes the growth of breast
cancer cells. Tamoxifen blocks the effects of estrogen on these cells.
It is often called an antiestrogen.
Tamoxifen is most effective for treating breast cancer that tests
positive for estrogen receptors (ER+). Tamoxifen is also used to
reduce the risk of breast cancer for women who have a high risk of
developing breast cancer.'.
While it must be true, I wonder what you have to say about it. Do let
me know!
Regards, sherry bove
A.P. Thorsen - 04 Mar 2007 18:21 GMT
<snip "Sherry's" quasi-form letter with pointless quote from prominently
linked wannabe medical web site followed by equally pointless non-question>
Promo-bot or liveware shill, ya think?
If liveware: Oooooo -- very lame. Too much free time!
We now return to our previous productive Tamoxifen thread, as contributed to
by our own Tim, Bea, et al. . . . .
Ann T.
Remove "dontsendspam" from address to reply by email
Tim Jackson - 04 Mar 2007 21:21 GMT
> <snip "Sherry's" quasi-form letter with pointless quote from prominently
> linked wannabe medical web site followed by equally pointless non-question>
[quoted text clipped - 8 lines]
> Ann T.
> Remove "dontsendspam" from address to reply by email
It's a well known promo. Not been known to react to replies.
Same as "mayihelpyou", but at least this one is on topic, so it's hard
to find grounds for a complaint.
Tim